Centro Di Riferimento Oncologico Di Aviano

Thoracic Oncology

Clinical research in ALK-positive non-small cell lung cancer with a focus on treatment-resistant disease and post-lorlatinib management.

  • Non-small cell lung cancer
  • ALK-rearranged disease
  • Extracranial progression

Interest centers on systemic treatment strategies for advanced lung cancer and the sequencing of targeted and chemotherapy-based approaches.

Breast Cancer and Metastatic Disease

Research spans breast carcinoma and metastatic breast cancer, including HR-positive, HER2-negative disease and biomarker-informed treatment selection.

  • Metastatic breast cancer
  • Hormone receptor-positive, HER2-negative disease
  • Liquid biopsy

Clinical interest includes treatment personalization in advanced breast cancer and the use of molecular markers to guide second-line decision making.

Rectal Cancer and Multimodal Therapy

Studies address high-risk rectal cancer with emphasis on combined chemotherapy, radiochemotherapy, and surgery-oriented treatment pathways.

  • Rectal carcinoma
  • Neoadjuvant treatment
  • Pathological complete remission

The therapeutic focus is on locally advanced colorectal disease and preoperative disease control.

Surgical Oncology and Intraoperative Imaging

Research includes axillary lymph node assessment in breast cancer surgery, with attention to indocyanine green fluorescence and nodal visualization.

  • Axillary surgery
  • Fluorescence imaging
  • Lymph node mapping

Interest lies in surgical guidance for nodal disease evaluation and operative planning in breast malignancy.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effectiveness and Safety of Carboplatin, Pemetrexed, and Lorlatinib for ALK Positive Non-Small Cell Lung Cancer with Extracranial Progression

    Recruiting

    2 1 1 1
    Investigated diseases:
    Italy
  • Study on Indocyanine Green in Axillary Lymph Nodes for Patients with Breast Cancer and Metastatic Lymph Nodes

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Cabozantinib Monitoring for Toxicity Management in Patients with Renal Cell Carcinoma

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Personalizing treatment for patients with HR-positive, HER2-negative metastatic breast cancer using fulvestrant, elacestrant, capivasertib, capecitabine, or a drug combination.

    Not yet recruiting

    2 1 1 1
    Italy
  • Study on Capecitabine and Oxaliplatin for Patients with High Risk Rectal Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy